RETROSPECTIVE ANALYSIS OF BORDERLINE OVARIAN TUMORS: OUTCOMES AT A SINGLE CENTER. 2019

Ercan Yilmaz, and Nurhan Sahin, and Isil Koleli, and Rauf Melekoglu, and Emrullah Tanrikut, and Simge Faydali, and Abdullah Karaer, and Ebru Inci Coskun
1Inonu University Turgut Ozal Medical Centre, Obstetrics and Gynecology Department, Malatya, Turkey; 2Inonu University Turgut Ozal Medical Centre, Pathology Department, Malatya, Turkey; 3Gozde Academy, Malatya, Turkey.

We wanted to discuss our experiences in the approach to borderline ovarian tumors, which constitute a group different from epithelial ovarian tumors with respect to their biological structure in line with retrospective information gathered from our cases. A total of 25 patients operated on for the indication of adnexal masses diagnosed as borderline ovarian tumors based on frozen section results were included in our study. Patient age, tumor diameter, tumor markers and surgeries performed were discussed in the light of the literature. Statistical analyses were performed using the SPSS software. The patient mean age was 43.84±11.34 years. The mass was localized in the right (n=13), left (n=11) or both (n=1) adnexal regions. The mean tumor diameter was 12.9±5.84 cm. Histopathologic examination established the diagnosis of serous borderline (n=14 patients) and mucinous borderline (n=11) ovarian tumors. Although the results of our study are consistent with current literature data, a greater number of current studies should be performed on borderline ovarian tumors, which are defined as a class of tumors different from epithelial ovarian tumors.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D002288 Adenocarcinoma, Mucinous An adenocarcinoma producing mucin in significant amounts. (From Dorland, 27th ed) Carcinoma, Colloid,Carcinoma, Mucinous,Adenocarcinomas, Mucinous,Carcinomas, Colloid,Carcinomas, Mucinous,Colloid Carcinoma,Colloid Carcinomas,Mucinous Adenocarcinoma,Mucinous Adenocarcinomas,Mucinous Carcinoma,Mucinous Carcinomas
D005260 Female Females
D005629 Frozen Sections Thinly cut sections of frozen tissue specimens prepared with a cryostat or freezing microtome. Frozen Section,Section, Frozen,Sections, Frozen
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D014408 Biomarkers, Tumor Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS. Biochemical Tumor Marker,Cancer Biomarker,Carcinogen Markers,Markers, Tumor,Metabolite Markers, Neoplasm,Tumor Biomarker,Tumor Marker,Tumor Markers, Biochemical,Tumor Markers, Biological,Biochemical Tumor Markers,Biological Tumor Marker,Biological Tumor Markers,Biomarkers, Cancer,Marker, Biochemical Tumor,Marker, Biologic Tumor,Marker, Biological Tumor,Marker, Neoplasm Metabolite,Marker, Tumor Metabolite,Markers, Biochemical Tumor,Markers, Biological Tumor,Markers, Neoplasm Metabolite,Markers, Tumor Metabolite,Metabolite Markers, Tumor,Neoplasm Metabolite Markers,Tumor Markers, Biologic,Tumor Metabolite Marker,Biologic Tumor Marker,Biologic Tumor Markers,Biomarker, Cancer,Biomarker, Tumor,Cancer Biomarkers,Marker, Tumor,Markers, Biologic Tumor,Markers, Carcinogen,Metabolite Marker, Neoplasm,Metabolite Marker, Tumor,Neoplasm Metabolite Marker,Tumor Biomarkers,Tumor Marker, Biochemical,Tumor Marker, Biologic,Tumor Marker, Biological,Tumor Markers,Tumor Metabolite Markers

Related Publications

Ercan Yilmaz, and Nurhan Sahin, and Isil Koleli, and Rauf Melekoglu, and Emrullah Tanrikut, and Simge Faydali, and Abdullah Karaer, and Ebru Inci Coskun
January 2015, Archives of gynecology and obstetrics,
Ercan Yilmaz, and Nurhan Sahin, and Isil Koleli, and Rauf Melekoglu, and Emrullah Tanrikut, and Simge Faydali, and Abdullah Karaer, and Ebru Inci Coskun
January 2014, European journal of gynaecological oncology,
Ercan Yilmaz, and Nurhan Sahin, and Isil Koleli, and Rauf Melekoglu, and Emrullah Tanrikut, and Simge Faydali, and Abdullah Karaer, and Ebru Inci Coskun
October 2010, Journal of pediatric surgery,
Ercan Yilmaz, and Nurhan Sahin, and Isil Koleli, and Rauf Melekoglu, and Emrullah Tanrikut, and Simge Faydali, and Abdullah Karaer, and Ebru Inci Coskun
January 2016, Journal of the Turkish German Gynecological Association,
Ercan Yilmaz, and Nurhan Sahin, and Isil Koleli, and Rauf Melekoglu, and Emrullah Tanrikut, and Simge Faydali, and Abdullah Karaer, and Ebru Inci Coskun
January 2023, Journal of ovarian research,
Ercan Yilmaz, and Nurhan Sahin, and Isil Koleli, and Rauf Melekoglu, and Emrullah Tanrikut, and Simge Faydali, and Abdullah Karaer, and Ebru Inci Coskun
February 2001, Minerva ginecologica,
Ercan Yilmaz, and Nurhan Sahin, and Isil Koleli, and Rauf Melekoglu, and Emrullah Tanrikut, and Simge Faydali, and Abdullah Karaer, and Ebru Inci Coskun
November 2022, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology,
Ercan Yilmaz, and Nurhan Sahin, and Isil Koleli, and Rauf Melekoglu, and Emrullah Tanrikut, and Simge Faydali, and Abdullah Karaer, and Ebru Inci Coskun
January 2022, American journal of translational research,
Ercan Yilmaz, and Nurhan Sahin, and Isil Koleli, and Rauf Melekoglu, and Emrullah Tanrikut, and Simge Faydali, and Abdullah Karaer, and Ebru Inci Coskun
February 2022, European journal of obstetrics, gynecology, and reproductive biology,
Ercan Yilmaz, and Nurhan Sahin, and Isil Koleli, and Rauf Melekoglu, and Emrullah Tanrikut, and Simge Faydali, and Abdullah Karaer, and Ebru Inci Coskun
January 2008, European journal of gynaecological oncology,
Copied contents to your clipboard!